Business · 08/04/2022Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Whole Slide Imaging in Nonclinical Toxicology Studies
Summary
The FDA has released a draft guidance document to clarify the management and use of whole slide images in nonclinical toxicology studies, addressing documentation practices and GLP compliance
Original source language: Federal Register — Food and Drug AdministrationOpen original release →